Monogram Net Income From Continuing Ops from 2010 to 2024
| MGRM Stock | 2.33 0.28 13.66% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -13.2 M | Current Value -13.9 M | Quarterly Volatility 5.2 M |
Check Monogram Orthopaedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Monogram Orthopaedics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 433 K, Interest Expense of 18.5 K or Selling General Administrative of 4.3 M, as well as many indicators such as Price To Sales Ratio of 417, Dividend Yield of 0.0 or PTB Ratio of 6.04. Monogram financial statements analysis is a perfect complement when working with Monogram Orthopaedics Valuation or Volatility modules.
Monogram | Net Income From Continuing Ops |
Latest Monogram Orthopaedics' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Monogram Orthopaedics Common over the last few years. It is Monogram Orthopaedics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Monogram Orthopaedics' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Monogram Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (5,306,638) | |
| Coefficient Of Variation | (98.89) | |
| Mean Deviation | 4,680,497 | |
| Median | (1,796,265) | |
| Standard Deviation | 5,247,751 | |
| Sample Variance | 27.5T | |
| Range | 12.1M | |
| R-Value | (0.83) | |
| Mean Square Error | 9T | |
| R-Squared | 0.70 | |
| Significance | 0.0001 | |
| Slope | (979,470) | |
| Total Sum of Squares | 385.5T |
Monogram Net Income From Continuing Ops History
About Monogram Orthopaedics Financial Statements
Monogram Orthopaedics investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Monogram Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -13.2 M | -13.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Monogram Orthopaedics Correlation against competitors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.